Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for Thoracic Duct Drainage (TDD) in renal transplants, effective May 15, 2026. Here's what billing teams need to know before that date.
CMS thoracic duct drainage coverage policy changes don't come along often, but when they do, they hit transplant programs hard. This modification affects how Medicare evaluates TDD as an adjunct procedure in kidney transplantation — a niche but financially significant area for academic medical centers and high-volume transplant programs. The policy does not list specific CPT, HCPCS, or ICD-10 codes in the published document, so you'll need to work closely with your coding team to identify the applicable procedure codes in your charge capture system.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Thoracic Duct Drainage (TDD) in Renal Transplants |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | Medium-High for transplant programs billing Medicare |
| Specialties Affected | Transplant surgery, nephrology, general surgery, hospital revenue cycle |
| Key Action | Audit your transplant procedure billing workflows before May 15, 2026 and confirm your coding team has identified applicable procedure codes |
CMS Thoracic Duct Drainage Coverage Criteria and Medical Necessity Requirements 2026
TDD in the context of renal transplantation is not a routine procedure. It has a specific clinical rationale — draining lymph from the thoracic duct to reduce immune cell load and prolong graft survival — and CMS has historically treated it as a procedure that requires clear medical necessity documentation before reimbursement.
The real issue here is that "modified" coverage policies from CMS often shift the medical necessity bar without clearly telegraphing exactly how. Whether this update tightens or relaxes the criteria for TDD matters enormously for transplant programs that have been billing consistently under prior expectations.
Because the published policy document does not include specific CPT or HCPCS codes, you cannot assume your existing charge capture maps correctly to whatever criteria this modification establishes. The absence of published codes is itself a red flag. Pull the full policy text from the CMS source at https://app.payerpolicy.org/p/cms/79-v1 and get your compliance officer in the room before May 15, 2026.
What "Medical Necessity" Means Here
CMS coverage policy for surgical adjuncts in transplantation generally requires that the procedure be:
| # | Covered Indication |
|---|---|
| 1 | Documented as clinically indicated based on the patient's specific immunological profile or transplant risk factors |
| 2 | Performed in a setting with appropriate institutional transplant credentials |
| 3 | Supported by contemporaneous documentation in the medical record — not reconstructed after the fact |
For TDD specifically, your documentation needs to show why this drainage procedure was necessary for this patient, at this time, in addition to the primary renal transplant. Generic documentation won't survive a post-payment audit. Medical necessity is not a checkbox — it's a narrative supported by objective clinical findings.
If your transplant surgeons aren't documenting the rationale for TDD as a distinct clinical decision, start that conversation now. The effective date of May 15, 2026 gives you a narrow window to fix documentation habits before new claims go out under the modified policy.
Prior Authorization Considerations
The published policy does not explicitly address prior authorization requirements for TDD in renal transplants. That said, prior auth requirements for intraoperative adjunct procedures in transplant surgery are often handled at the Medicare Administrative Contractor (MAC) level, not in a national CMS policy.
Contact your MAC directly to confirm whether prior authorization applies to TDD under the revised policy. Don't assume the absence of a stated requirement means no requirement exists. MAC-level local coverage determinations (LCDs) can impose prior auth requirements that a national policy doesn't mention.
CMS Thoracic Duct Drainage Exclusions and Non-Covered Indications
The published policy document does not list specific exclusions or non-covered indications for TDD in renal transplants. This is a problem, not a relief.
When CMS modifies a policy without clearly enumerating exclusions, billing teams often discover those exclusions the hard way — through claim denial. The pattern is familiar: a program bills TDD as it always has, a claim comes back denied, and the denial reason references the modified policy criteria that nobody fully mapped to the billing workflow.
Don't wait for a denial to learn what's excluded. Request the full policy text, compare it line by line to the prior version, and flag any language that narrows the covered indications. If you don't have access to version-comparison tools, your compliance officer or billing consultant needs to pull both versions manually.
Coverage Indications at a Glance
Because the published policy document does not provide specific indication-level criteria or associated codes, a standard indications table cannot be built from the available data. The table below reflects what is known and where gaps exist.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| TDD as adjunct to renal transplantation | Modified — exact criteria not specified in published document | Not published in policy | Confirm coverage criteria with your MAC before billing after May 15, 2026 |
| TDD outside renal transplant context | Unknown from this policy | Not published | Likely governed by separate coverage rules — do not assume coverage transfers |
Your coding team should not attempt to extrapolate coverage from this table alone. Get the full policy text and a code-level analysis from your compliance officer or a transplant billing specialist.
CMS Thoracic Duct Drainage Billing Guidelines and Action Items 2026
Here's what your team does between now and May 15, 2026.
| # | Action Item |
|---|---|
| 1 | Pull the full policy text immediately. Access the published policy at https://app.payerpolicy.org/p/cms/79-v1. Compare the current version to the prior version line by line. The word "modified" tells you something changed — you need to know exactly what. |
| 2 | Identify the applicable procedure codes in your charge master. The policy does not publish specific CPT or HCPCS codes for thoracic duct drainage in renal transplants. Work with your coding team to identify every code currently mapped to TDD procedures in your charge capture system. Flag those codes for review against the modified criteria before the effective date. |
| 3 | Contact your MAC about local coverage determinations. National CMS policies don't always tell the whole story. Your MAC may have an LCD that governs TDD billing in your region. Call them. Ask specifically whether this policy modification triggers any change in local prior authorization requirements or documentation standards. |
| 4 | Audit your documentation templates. Sit down with your transplant surgery team before May 15, 2026 and review the operative note templates and clinical documentation used for cases where TDD is performed. Every case should include a clear, patient-specific rationale for TDD as a distinct clinical decision. If your templates don't support that, update them now. |
| 5 | Review claims filed in the 90 days before the effective date. If CMS is modifying this policy because of coverage disputes or audit findings, there's a chance retrospective scrutiny follows. Pull TDD-related claims from the prior 90 days, confirm documentation is solid, and address any gaps before they become recovery audit targets. |
| 6 | Talk to your compliance officer before the effective date. This policy modification has gaps — no published codes, no explicit exclusion list, no stated prior auth requirements. That ambiguity creates real claim denial risk. If you're not certain how the modified criteria apply to your transplant program's specific billing mix, loop in your compliance officer now. Don't wait until a denial forces the conversation. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Thoracic Duct Drainage in Renal Transplants Under This Policy
The CMS policy for Thoracic Duct Drainage in Renal Transplants does not list specific CPT, HCPCS, or ICD-10 codes in the published document. Do not use codes from external sources or prior policy versions without confirming they apply under the modified criteria.
Your coding team should work from current CPT code books and confirm code selection with your MAC. Transplant billing is complex — thoracic duct drainage may be captured as a distinct procedure code or bundled with the primary transplant procedure depending on payer rules and the specific clinical scenario.
Until the applicable codes are confirmed through the full policy text and MAC guidance, treat TDD thoracic duct drainage billing as requiring manual review on every claim. Automated charge capture rules carry real claim denial risk when the code mapping hasn't been validated against a modified policy.
If you need help identifying the correct code set for TDD in your specific procedure mix, work with a billing consultant who specializes in transplant surgery reimbursement. This is not the place for guesswork.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.